drugset
drugset / Trial / NCT02164110

To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children

NCT02164110 ↗

Phase 3 Completed 3632 enrolled EuBiologics Co.,Ltd Instituto Universitario IVI · collab
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to evaluate the efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children.

Timeline

Start
2014-05
Primary completion
2014-09
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Euvichol Vaccine 1.5 ml Oral
Comparator Shanchol Vaccine 1.5 ml Oral

Indications

No indication recorded.